Personal information

Drug Discovery Technologies
United Kingdom

Activities

Employment (6)

University of Edinburgh: Edinburgh, Edinburgh, GB

2008-11-01 to present | Scottish Universities Life Sciences Allience (SULSA) Professor of Chemical and Translational Biology (School of Biological Sciences, Institute of Quantitative Biology, Biotechnology and Biochemistry )
Employment
Source: Self-asserted source
Manfred Auer

Novartis Institutes for BioMedical Research: Basel, Basel-Stadt, CH

2004-07 to 2007-09 | Senior Unit Head / Executive Director, “Innovative Screening Technologies” (NIBR Discovery Technologies)
Employment
Source: Self-asserted source
Manfred Auer

Novartis: Basel, CH

2001-07 to 2004-06 | Unit Head for “Innovative Screening Technologies” (Novartis Lead Discovery Centre)
Employment
Source: Self-asserted source
Manfred Auer

Novartis: Vienna, Vienna, AT

2001-07 to 2004-06 | Program Head, “Confocal Screening Technologies" (Innovative Screening Technologies)
Employment
Source: Self-asserted source
Manfred Auer

Novartis-Research Institute: Vienna, Vienna, AT

1998-08 to 2001-07 | Research Programme Head: “Fluorescence based High-Throughput Screening Technology”
Employment
Source: Self-asserted source
Manfred Auer

Sandoz/Novartis Research Institute : Vienna, Vienna, AT

1989-01 to 1998-07 | Senior Scientist / Laborleiter
Employment
Source: Self-asserted source
Manfred Auer

Education and qualifications (4)

University of Salzburg: Salzburg, AT

1998-06-25 to present | Habilitation, “venia docendi”, Biophysical Chemistry / Univ. Dozent (Faculty of Natural Science)
Qualification
Source: Self-asserted source
Manfred Auer

Max Planck Institute for Medical Research: Heidelberg, DE

1985 to 1989 | Ph.D. thesis / Dr. rer. nat., (University of Innsbruck, with distinction ) (Biophysics)
Education
Source: Self-asserted source
Manfred Auer

University of Innsbruck: Innsbruck, AT

1976 to 1984 | Diploma thesis - Chemistry / Mag. rer.nat. (distinction) (Chemistry/Physics)
Education
Source: Self-asserted source
Manfred Auer

Mathematisches Bundesrealgymnasium: Innsbruck, Tirol, AT

1964 to 1976-06-11 | Reifeprüfung (general qualification for university entrance, with distinction)
Education
Source: Self-asserted source
Manfred Auer

Professional activities (17)

MDPI AG: Basel, BS, CH

2018-07-31 to present | Member of the Editorial Board (Methods & Protocols)
Service
Source: Self-asserted source
Manfred Auer

University of Edinburgh School of Biological Sciences: Edinburgh, Edinburgh, GB

2015-10-15 to present | Member (UK Centre for Mammalian Synthetic Biology)
Invited position
Source: Self-asserted source
Manfred Auer

Parkinson's UK: London, GB

2015 to present | Member (Drug Discovery Advisory Panel )
Invited position
Source: Self-asserted source
Manfred Auer

Celcuity LLC: Minneapolis, US

2015 to present | Member of the Scientific Advisory Board
Invited position
Source: Self-asserted source
Manfred Auer

University of Edinburgh School of Biological Sciences: Edinburgh, Edinburgh, GB

2014-03-19 to present | Associate Member (Scottish Centre for Regenerative Medicine (SCRM))
Invited position
Source: Self-asserted source
Manfred Auer

IOP Publishing Ltd: Bristol, Bristol, GB

2012-08-07 to present | Member of the Editorial Board (Methods and Applications in Fluorescence – MAF )
Service
Source: Self-asserted source
Manfred Auer

University of Montreal: Montreal, Quebec, CA

2012-03-14 to present | Associate Investigator (Institute of Research in Immunology and Cancer (IRIC))
Invited position
Source: Self-asserted source
Manfred Auer

University of Edinburgh School of Biological Sciences: Edinburgh, Edinburgh, GB

2012 to present | Member (Centre for Synthetic and Systems Biology /SynthSys)
Invited position
Source: Self-asserted source
Manfred Auer

University of Edinburgh School of Biological Sciences: Edinburgh, Edinburgh, GB

2011-12-16 to present | Member / Translational Facilitator (Centre for Immunity, Infection and Evolution, (CIIE) )
Invited position
Source: Self-asserted source
Manfred Auer

University of Edinburgh School of Biomedical Sciences: Edinburgh, Edinburgh, GB

2009-04-01 to present | Member (Division of Infection Pathway Medicine)
Invited position
Source: Self-asserted source
Manfred Auer

University of Edinburgh School of Biological Sciences: Edinburgh, Edinburgh, GB

2009-01-05 to present | Member (Centre for Systems Biology)
Invited position
Source: Self-asserted source
Manfred Auer

University of Edinburgh School of Biological Sciences: Edinburgh, Edinburgh, GB

2008-11-01 to present | Member (Centre for Translational & Chemical Biology(CTCB))
Invited position
Source: Self-asserted source
Manfred Auer

Springer International Publishing AG: Cham, CH

2008 to 2017 | Member of the Editorial Board (Journal of Chemical Biology)
Service
Source: Self-asserted source
Manfred Auer

University of Edinburgh School of Biological Sciences: Edinburgh, Edinburgh, GB

2009 to 2016 | Associate Member (Wellcome Trust Centre for Cell Biology (WTCCB))
Invited position
Source: Self-asserted source
Manfred Auer

University of Edinburgh School of Biological Sciences: Edinburgh, Edinburgh, GB

2011-01-27 to 2015-12-03 | Associate Director of Research – for Knowledge Transfer
Invited position
Source: Self-asserted source
Manfred Auer

Society for Biomolecular Screening : Oak Brook, US

2002-09-25 | Achievement Award 2002 for pioneering work in confocal fluorescence technologies and it’s applications to high throughput screening platforms.
Distinction
Source: Self-asserted source
Manfred Auer

Novartis Pharma AG: Basel, Basel-Stadt, CH

1999-12-02 | Novartis Leading Scientist, Lifetime Research Award and Title
Distinction
Source: Self-asserted source
Manfred Auer

Funding (25)

Progression in the development of a first in class 19F F-fragment library and application to the discovery of a new class of bacterial antitermination complex inhibitors for treatment of antibacterial infection.

2019 to 2020 | Grant
Wellcome Trust (London/Edinburgh, GB)
Source: Self-asserted source
Manfred Auer

Understanding bacterial host adaptation to combat infectious disease

2017 to 2020 | Award
Wellcome Trust (London, GB)
Source: Self-asserted source
Manfred Auer

Acquisition of a hydrogen-deuterium exchange HPLC (HDX) platform for structural protein analysis and protein-small molecule interaction.

2016 to present | Grant
Wellcome Trust (London, GB)
Source: Self-asserted source
Manfred Auer

Identification of peptidomimetics binding the epigenetic target ATPases associated with diverse cellular activities, ATAD2.

2014-08 to 2015-07 | Grant
Mary Kinross Seedcorn Award (London, GB)
Source: Self-asserted source
Manfred Auer

An Integrated Ultra-High-Throughput Platform for Chemical Systems Biology

2013 to present | Award
Canada Foundation for Innovation (ON, ON, CA)
Source: Self-asserted source
Manfred Auer

Combining stem cell and high throughput screening technologies to find new lead compound against alpha synuclein pathogenicity.

2013 to 2016 | Grant
Scottish Funding Council (Edinburgh, GB)
Source: Self-asserted source
Manfred Auer

Systematic discovery of small molecule ligands for the human WD40 domain family.

2013 to 2016 | Grant
Scottish Funding Council (Edinburgh, GB)
Source: Self-asserted source
Manfred Auer

Discovery of the next generation of anti-fungal peptidomimetic inhibitors.

2012 to present | Grant
Scottish Universities Life Sciences Alliance (Edinburgh, GB)
Source: Self-asserted source
Manfred Auer

Screening for hCINAP inhibitors, an emerging drug target for malignant diseases.

2012 to present | Grant
Scottish Universities Life Sciences Alliance (Edinburgh, GB)
Source: Self-asserted source
Manfred Auer

PRIMES: Protein interaction machines in oncogenic EGF receptor signalling

2011-12 to 2016-11 | Grant
FP7 Health (Brussels, BE)
Part of GRANT_NUMBER:

278568

Source: Self-asserted source
Manfred Auer

CIRINCA – Computational Iterative Replacement by Insertion of Non Coded Amino acids.

2011-08 to present | Award
University Of Edinburgh, Bioquarter (Edinburgh, GB)
Source: Self-asserted source
Manfred Auer

A new purine scaffold based TOBOC library for targeting ATPases and GTPases, production and screening.

2011-07 to present | Grant
Biotechnology and Biological Sciences Research Council (London, GB)
Source: Self-asserted source
Manfred Auer

Design and production of a tagged one-bead one-compound library (TOBOC Library) of purines as privileged scaffolds for inhibition of many enzyme classes (kinases, ATPases, GTPases, Polymerases) and receptors (GPCRs).

2011-07 to present | Grant
Scottish Universities Life Sciences Alliance (Edinburgh, GB)
Source: Self-asserted source
Manfred Auer

Sesmos Ltd

2011 to present | Grant
Siemens (Munich, DE)
Source: Self-asserted source
Manfred Auer

Design, synthesis and validation of Kisspeptin peptidomimetics for clinical development to create new medicines with utility in reproductive health.

2011 to 2014 | Grant
Biotechnology and Biological Sciences Research Council (London, GB)
Source: Self-asserted source
Manfred Auer

High-throughput NMR Facility” for translational and chemical biology.

2010-11 to present | Award
Wellcome Trust (London, GB)
Source: Self-asserted source
Manfred Auer

Targeting host and viral transcript stability: rational design of novel anti-viral oligo-nucleotides.

2010 to present | Grant
Biotechnology and Biological Sciences Research Council (London, GB)
Source: Self-asserted source
Manfred Auer

The exploitation of cellular imaging, cell manipulation and optoinjection provided by the LEAP instrument in cell biology, stem cell research, chemical biology and drug discovery

2010 to present | Grant
Biotechnology and Biological Sciences Research Council (London, GB)
Source: Self-asserted source
Manfred Auer

Wellcome-Wolfson award for Systems Medicine Building, Edinburgh

2010 to present | Award
Wellcome Trust (London, GB)
Source: Self-asserted source
Manfred Auer

Discovery of next-generation KMO inhibitors using advanced screening technology

2010 to 2014 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Manfred Auer

Award for synthesis of a small molecular H2-relaxin mimetic using a cell based compound screening strategy

2010 to 2011 | Grant
Wellcome Trust (London, GB)
Source: Self-asserted source
Manfred Auer

MRC Strategic Investment

2009 to present | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Manfred Auer

Chemical & Translational Biology Chair

2009 to 2017 | Award
Scottish Universities Life Sciences Allience (Edinburgh, GB)
Source: Self-asserted source
Manfred Auer

Cyclophilin Inhibitors as Antiviral Therapies

2009 to 2012 | Award
Medical Research Council (London, GB)
Source: Self-asserted source
Manfred Auer

Insight Inside: Signal transducing protein machines revealed by subcellular single molecule spectroscopy and imaging

2001 to 2006 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER:

QLG2-CT-2001-01428

Source: Self-asserted source
Manfred Auer

Peer review (3 reviews for 2 publications/grants)

Review activity for Bioconjugate chemistry. (2)
Review activity for Organic letters. (1)